Cogent Biosciences, Inc. (COGT)
36.19
-0.13
(-0.36%)
USD |
NASDAQ |
Apr 16, 16:00
36.18
-0.01
(-0.03%)
After-Hours: 20:00
Cogent Biosciences Free Cash Flow : -266.00M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Syndax Pharmaceuticals, Inc. | -323.17M |
| Vera Therapeutics, Inc. | -241.73M |
| Terns Pharmaceuticals, Inc. | -82.18M |
| Nuvalent, Inc. | -275.21M |
| Insmed, Inc. | -997.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -79.10M |
| Cash from Investing (Quarterly) | -322.77M |
| Cash from Financing (Quarterly) | 588.67M |
| Free Cash Flow Per Share (Quarterly) | -0.5406 |
| Free Cash Flow to Equity (Quarterly) | -258.15M |
| Free Cash Flow to Firm (Quarterly) | -78.63M |
| Free Cash Flow Yield | -5.73% |